2 completed, 2 terminated, 1 recruiting. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 2, Terminated 2, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Stage II Renal Cell Cancer: new trials by email Literature Review of Stage II Renal Cell Cancer trials Research Report on Stage II Renal Cell Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial Angiogram, Biospecimen Collection, Computed Tomography - Stage I Renal Cell Cancer, Stage II Renal Cell Cancer | Phase 1 / Phase 2 | Recruiting | Jonsson Comprehensive Cancer Center | 25 | 2024-12-26 | 2026-08-21 |
| Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer Interstitial Radiation Therapy - Stage I Renal Cell Cancer, Stage II Renal Cell Cancer | Phase 1 | Terminated | Jonsson Comprehensive Cancer Center | 2 | 2020-07-16 | 2026-08-20 |
| sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis, Radical Cystectomy - Infiltrating Bladder Urothelial Carcinoma, Recurrent Bladder Carcinoma | Phase 1 | Terminated | University of Southern California | 2 | 2016-08-02 | 2021-11-24 |
| Fluorescence Imaging in Finding Tumors in Patients With Kidney Tumors fluorescence imaging, laparoscopic surgery, indocyanine green - Recurrent Renal Cell Cancer, Stage I Renal Cell Cancer | Phase 1 | Completed | City of Hope Medical Center | 28 | 2011-10-20 | 2017-10-13 |
| Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies sunitinib malate, bevacizumab, pharmacological study - Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 6 | 2010-10-01 | 2014-04-02 |
Carcinoma, Renal Cell (5) · Prostatic Neoplasms (1) · Urinary Bladder Neoplasms (1)
Adenocarcinoma (5) · Carcinoma (5) · Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Kidney Diseases (5) · Kidney Neoplasms (5) · Male Urogenital Diseases (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms by Site (5) · Neoplasms, Glandular and Epithelial (5) · Urogenital Diseases (5) · Urogenital Neoplasms (5) · Urologic Diseases (5) · Urologic Neoplasms (5)
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1) · Bevacizumab (1) · Brachytherapy (1) · Cystectomy (1) · Indocyanine Green (1) · Laparoscopy (1) · Magnetic Resonance Spectroscopy (1) · Optical Imaging (1) · Photons (1) · Specimen Handling (1) · Sunitinib (1) · X-Rays (1) · alovudine (1)
Jonsson Comprehensive Cancer Center (2) · City of Hope Medical Center (1) · National Cancer Institute (NCI) (1) · University of Southern California (1)
United States (5)
Albert J Chang (1) · Clayton Lau, MD (1) · David I Quinn, MD (1) · Glenn Liu (1) · Siddharth A Padia (1)
P30CA014089 (1), P30CA014520 (1), U01CA062491 (1), U01CA070095 (1)